ReP USP - Resultado da busca

Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 10 nov. 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Artigo de periodico
DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
Souza, Márcia Maria de; Cenci, Arthur Ribeiro; Teixeira, Kerolain Faoro; Machado, Valkiria; Mendes, Majory Christina Garcia; Gonçalves, Ana Elisa; Dalmagro, Ana Paula; Cazarin, Camila André; Ferreira, Leonardo Luiz Gomes ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 10 nov. 2024.
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Artigo de periodico
2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations (2023)
Cuppoloni, Andréa; Silva, João Vitor da ; Snape, Timothy James ; Lal, Samridhi ; Giarolla, Jeanine
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: MEDICAMENTO, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 10 nov. 2024.
APA
Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752
NLM
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Vancouver
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1568026623666230207120752
Artigo de periodico
Cruzain inhibitors: state-of-art of novel synthetic strategies (2023)
Morais, Pedro Alves Bezerra ; Trossini, Gustavo Henrique Goulart
Source: Current Organic Chemistry. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 10 nov. 2024.
APA
Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
NLM
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Vancouver
Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272827666230418100932
Artigo de periodico-carta/editorial
Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach (2023)
Santos, Rafael Guimarães dos ; Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Öngür, Dost; Dursun, Serdar M.
Source: Current Neuropharmacology. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, ANTIDEPRESSIVOS, DEPRESSÃO, ANSIEDADE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1570159X20666220425133824. Acesso em: 10 nov. 2024. , 2023
APA
Santos, R. G. dos, Rossi, G. N., Hallak, J. E. C., Öngür, D., & Dursun, S. M. (2023). Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.2174/1570159X20666220425133824
NLM
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Vancouver
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Artigo de periodico
Characterization, antifungal evaluation against candida spp. strains and application of nystatin: β-cyclodextrin inclusion complexes (2023)
Urban, Amanda Migliorini ; Morikava, Francine Sumie ; Schoeffel, Amanda Cristina ; Novatski, Andressa ; Moraes, Gustavo Simão ; Cachoeira, Victoria Schlumberger ; Matioli, Graciette ; Ito, Carmen Antonia Sanches ; Ferrari, Priscileila Colerato ; Neppelenbroek, Karin Hermana ; Urban, Vanessa Migliorini ; Farago, Paulo Vitor
Source: Current Drug Delivery. Unidade: FOB
Subjects: ESTOMATITE SOB PRÓTESE, CANDIDA, LIOFILIZAÇÃO, FUNGICIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
URBAN, Amanda Migliorini et al. Characterization, antifungal evaluation against candida spp. strains and application of nystatin: β-cyclodextrin inclusion complexes. Current Drug Delivery, v. 20, n. 10, p. 1533-1546, 2023Tradução . . Disponível em: https://doi.org/10.2174/1567201820666221017103119. Acesso em: 10 nov. 2024.
APA
Urban, A. M., Morikava, F. S., Schoeffel, A. C., Novatski, A., Moraes, G. S., Cachoeira, V. S., et al. (2023). Characterization, antifungal evaluation against candida spp. strains and application of nystatin: β-cyclodextrin inclusion complexes. Current Drug Delivery, 20( 10), 1533-1546. doi:10.2174/1567201820666221017103119
NLM
Urban AM, Morikava FS, Schoeffel AC, Novatski A, Moraes GS, Cachoeira VS, Matioli G, Ito CAS, Ferrari PC, Neppelenbroek KH, Urban VM, Farago PV. Characterization, antifungal evaluation against candida spp. strains and application of nystatin: β-cyclodextrin inclusion complexes [Internet]. Current Drug Delivery. 2023 ; 20( 10): 1533-1546.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1567201820666221017103119
Vancouver
Urban AM, Morikava FS, Schoeffel AC, Novatski A, Moraes GS, Cachoeira VS, Matioli G, Ito CAS, Ferrari PC, Neppelenbroek KH, Urban VM, Farago PV. Characterization, antifungal evaluation against candida spp. strains and application of nystatin: β-cyclodextrin inclusion complexes [Internet]. Current Drug Delivery. 2023 ; 20( 10): 1533-1546.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1567201820666221017103119
Artigo de periodico
Extemporaneous compounding: a possible trigger tool to detect potential health incidents (2022)
Toma, Marina Massae; Santana, Gabriel de Freitas; Nadai, Tales Rubens de ; Varallo, Fabiana Rossi ; Benzi, Jhohann Richard de Lima ; Mastroianni, Patrícia de Carvalho
Source: Current Drug Safety. Unidades: FOB, FCFRP
Subjects: SEGURANÇA DO PACIENTE, FARMACOTERAPIA, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMA, Marina Massae et al. Extemporaneous compounding: a possible trigger tool to detect potential health incidents. Current Drug Safety, v. 17, n. 3, p. 183-192, 2022Tradução . . Disponível em: https://doi.org/10.2174/1574886316666211014155946. Acesso em: 10 nov. 2024.
APA
Toma, M. M., Santana, G. de F., Nadai, T. R. de, Varallo, F. R., Benzi, J. R. de L., & Mastroianni, P. de C. (2022). Extemporaneous compounding: a possible trigger tool to detect potential health incidents. Current Drug Safety, 17( 3), 183-192. doi:10.2174/1574886316666211014155946
NLM
Toma MM, Santana G de F, Nadai TR de, Varallo FR, Benzi JR de L, Mastroianni P de C. Extemporaneous compounding: a possible trigger tool to detect potential health incidents [Internet]. Current Drug Safety. 2022 ; 17( 3): 183-192.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1574886316666211014155946
Vancouver
Toma MM, Santana G de F, Nadai TR de, Varallo FR, Benzi JR de L, Mastroianni P de C. Extemporaneous compounding: a possible trigger tool to detect potential health incidents [Internet]. Current Drug Safety. 2022 ; 17( 3): 183-192.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1574886316666211014155946
Artigo de periodico
Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Synthesized by Micellar Approach as a Potential Dual-Mode T1-T2 Contrast Agent (2022)
Beck Jr, Watson; Varanda, Laudemir Carlos ; Lopes, Simone Jaqueline dos Santos; Moraes, Daniel Angeli de ; Santos, Natalia M.; Lino, Maria Eduarda S. D.
Source: Current Nanomedicine. Unidade: IQSC
Subjects: NANOPARTÍCULAS, FERRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BECK JR, Watson et al. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Synthesized by Micellar Approach as a Potential Dual-Mode T1-T2 Contrast Agent. Current Nanomedicine, v. 12, p. 63-75, 2022Tradução . . Disponível em: https://doi.org/10.2174/2468187312666220509213555. Acesso em: 10 nov. 2024.
APA
Beck Jr, W., Varanda, L. C., Lopes, S. J. dos S., Moraes, D. A. de, Santos, N. M., & Lino, M. E. S. D. (2022). Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Synthesized by Micellar Approach as a Potential Dual-Mode T1-T2 Contrast Agent. Current Nanomedicine, 12, 63-75. doi:10.2174/2468187312666220509213555
NLM
Beck Jr W, Varanda LC, Lopes SJ dos S, Moraes DA de, Santos NM, Lino MESD. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Synthesized by Micellar Approach as a Potential Dual-Mode T1-T2 Contrast Agent [Internet]. Current Nanomedicine. 2022 ;12 63-75.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/2468187312666220509213555
Vancouver
Beck Jr W, Varanda LC, Lopes SJ dos S, Moraes DA de, Santos NM, Lino MESD. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Synthesized by Micellar Approach as a Potential Dual-Mode T1-T2 Contrast Agent [Internet]. Current Nanomedicine. 2022 ;12 63-75.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/2468187312666220509213555
Artigo de periodico
An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone (2022)
Queiroz, Jaqueline E.; Dias, Lucas Danilo ; Vila Verde, Giuliana M.; Aquino, Gilberto L. B.; Camargo, Ademir J.
Source: Current Organic Chemistry. Unidade: IFSC
Subjects: PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROZ, Jaqueline E. et al. An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone. Current Organic Chemistry, v. 26, n. 2, p. 81-90, 2022Tradução . . Disponível em: https://doi.org/10.2174/1385272826666220119110347. Acesso em: 10 nov. 2024.
APA
Queiroz, J. E., Dias, L. D., Vila Verde, G. M., Aquino, G. L. B., & Camargo, A. J. (2022). An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone. Current Organic Chemistry, 26( 2), 81-90. doi:10.2174/1385272826666220119110347
NLM
Queiroz JE, Dias LD, Vila Verde GM, Aquino GLB, Camargo AJ. An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone [Internet]. Current Organic Chemistry. 2022 ; 26( 2): 81-90.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272826666220119110347
Vancouver
Queiroz JE, Dias LD, Vila Verde GM, Aquino GLB, Camargo AJ. An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone [Internet]. Current Organic Chemistry. 2022 ; 26( 2): 81-90.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272826666220119110347
Artigo de periodico
Pulmonary tuberculosis in people with HIV: a cross-sectional study on the characteristics associated with the negative result of GeneXpert® MTB/RIF (2022)
Faria, Mariana Gaspar Botelho Funari de ; Andrade, Rubia Laine de Paula; Sousa, Keila Diane Lima de; Leite, Karina Fonseca de Souza; Bonfim, Rafaele Oliveira ; Ferreira, Melisane Regina Lima; Abreu, Paula Daniella de ; Bollela, Valdes Roberto; Arcêncio, Ricardo Alexandre ; Rezende, Carlos Eduardo Menezes de; Magnabosco, Gabriela Tavares; Ruffino Netto, Antônio ; Villa, Tereza Cristina Scatena ; Monroe, Aline Aparecida
Source: Research & Reviews: Journal of Nursing and Health Sciences. Unidades: EERP, FMRP
Subjects: TUBERCULOSE, HIV, DIAGNÓSTICO, TÉCNICAS DE DIAGNÓSTICO MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, Mariana Gaspar Botelho Funari de et al. Pulmonary tuberculosis in people with HIV: a cross-sectional study on the characteristics associated with the negative result of GeneXpert® MTB/RIF. Research & Reviews: Journal of Nursing and Health Sciences, v. 8, n. 9, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.4172/JNHS.2022.8.9.42. Acesso em: 10 nov. 2024.
APA
Faria, M. G. B. F. de, Andrade, R. L. de P., Sousa, K. D. L. de, Leite, K. F. de S., Bonfim, R. O., Ferreira, M. R. L., et al. (2022). Pulmonary tuberculosis in people with HIV: a cross-sectional study on the characteristics associated with the negative result of GeneXpert® MTB/RIF. Research & Reviews: Journal of Nursing and Health Sciences, 8( 9), 1-7. doi:10.4172/JNHS.2022.8.9.42
NLM
Faria MGBF de, Andrade RL de P, Sousa KDL de, Leite KF de S, Bonfim RO, Ferreira MRL, Abreu PD de, Bollela VR, Arcêncio RA, Rezende CEM de, Magnabosco GT, Ruffino Netto A, Villa TCS, Monroe AA. Pulmonary tuberculosis in people with HIV: a cross-sectional study on the characteristics associated with the negative result of GeneXpert® MTB/RIF [Internet]. Research & Reviews: Journal of Nursing and Health Sciences. 2022 ; 8( 9): 1-7.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4172/JNHS.2022.8.9.42
Vancouver
Faria MGBF de, Andrade RL de P, Sousa KDL de, Leite KF de S, Bonfim RO, Ferreira MRL, Abreu PD de, Bollela VR, Arcêncio RA, Rezende CEM de, Magnabosco GT, Ruffino Netto A, Villa TCS, Monroe AA. Pulmonary tuberculosis in people with HIV: a cross-sectional study on the characteristics associated with the negative result of GeneXpert® MTB/RIF [Internet]. Research & Reviews: Journal of Nursing and Health Sciences. 2022 ; 8( 9): 1-7.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4172/JNHS.2022.8.9.42
Artigo de periodico
Recommended non-pharmacological measures to prevent and control Covid-19 in the prison system: a scoping review (2022)
Bernardi, Willie Otávio Bueno; Ferreira, Melisane Regina Lima; Saita, Nanci Michele; Sousa, Keila Diane Lima de; Andrade, Rubia Laine de Paula; Yamamura, Mellina; Monroe, Aline Aparecida
Source: Research & Reviews: Journal of Nursing and Health Sciences. Unidade: EERP
Subjects: INFECÇÕES POR CORONAVIRUS, COVID-19, PRISÕES, PREVENÇÃO DE DOENÇAS, CONTROLE DE DOENÇAS TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDI, Willie Otávio Bueno et al. Recommended non-pharmacological measures to prevent and control Covid-19 in the prison system: a scoping review. Research & Reviews: Journal of Nursing and Health Sciences, v. 8, n. 10, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.4172/JNHS.2022.8.10.48. Acesso em: 10 nov. 2024.
APA
Bernardi, W. O. B., Ferreira, M. R. L., Saita, N. M., Sousa, K. D. L. de, Andrade, R. L. de P., Yamamura, M., & Monroe, A. A. (2022). Recommended non-pharmacological measures to prevent and control Covid-19 in the prison system: a scoping review. Research & Reviews: Journal of Nursing and Health Sciences, 8( 10), 1-11. doi:10.4172/JNHS.2022.8.10.48
NLM
Bernardi WOB, Ferreira MRL, Saita NM, Sousa KDL de, Andrade RL de P, Yamamura M, Monroe AA. Recommended non-pharmacological measures to prevent and control Covid-19 in the prison system: a scoping review [Internet]. Research & Reviews: Journal of Nursing and Health Sciences. 2022 ; 8( 10): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4172/JNHS.2022.8.10.48
Vancouver
Bernardi WOB, Ferreira MRL, Saita NM, Sousa KDL de, Andrade RL de P, Yamamura M, Monroe AA. Recommended non-pharmacological measures to prevent and control Covid-19 in the prison system: a scoping review [Internet]. Research & Reviews: Journal of Nursing and Health Sciences. 2022 ; 8( 10): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.4172/JNHS.2022.8.10.48
Artigo de periodico
Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats (2022)
Marín-Prida, Javier; Liberato, José Luiz ; Llópiz-Arzuaga, Alexey; Padovani, Karina Stringhetta; Pavón-Fuentes, Nancy; Leopoldino, Andréia Machado ; Cruz, Osmany Guirola; González, Ignacio Hernández; Pérez, Mariela León; Camins, Antoni; Santos, Wagner Ferreira dos; Uyemura, Sergio Akira ; Pardo-Andreu, Gilberto L.; Pentón-Rol, Giselle
Source: Current Pharmaceutical Design. Unidades: FCFRP, FFCLRP, FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, ISQUEMIA CEREBRAL, FARMACOTERAPIA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARÍN-PRIDA, Javier et al. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats. Current Pharmaceutical Design, v. 28, n. 14, p. 1187-1197, 2022Tradução . . Disponível em: https://doi.org/10.2174/1381612828666220506145542. Acesso em: 10 nov. 2024.
APA
Marín-Prida, J., Liberato, J. L., Llópiz-Arzuaga, A., Padovani, K. S., Pavón-Fuentes, N., Leopoldino, A. M., et al. (2022). Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats. Current Pharmaceutical Design, 28( 14), 1187-1197. doi:10.2174/1381612828666220506145542
NLM
Marín-Prida J, Liberato JL, Llópiz-Arzuaga A, Padovani KS, Pavón-Fuentes N, Leopoldino AM, Cruz OG, González IH, Pérez ML, Camins A, Santos WF dos, Uyemura SA, Pardo-Andreu GL, Pentón-Rol G. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats [Internet]. Current Pharmaceutical Design. 2022 ; 28( 14): 1187-1197.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1381612828666220506145542
Vancouver
Marín-Prida J, Liberato JL, Llópiz-Arzuaga A, Padovani KS, Pavón-Fuentes N, Leopoldino AM, Cruz OG, González IH, Pérez ML, Camins A, Santos WF dos, Uyemura SA, Pardo-Andreu GL, Pentón-Rol G. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats [Internet]. Current Pharmaceutical Design. 2022 ; 28( 14): 1187-1197.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1381612828666220506145542
Artigo de periodico
Sustainable synthesis of benzylidenemalononitrile compounds under microwave irradiation (2022)
Jimenez, David Esteban Quintero ; Zanin, Lucas Lima ; Ferreira, Irlon Maciel ; Deflon, Victor Marcelo ; Diniz, Luan F. ; Ellena, Javier ; Haiduke, Roberto Luiz Andrade ; Porto, Andre Luiz Meleiro
Source: Current Organic Chemistry. Unidades: IQSC, IFSC
Subjects: DIFRAÇÃO POR RAIOS X, FOTOQUÍMICA, QUÍMICA VERDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIMENEZ, David Esteban Quintero et al. Sustainable synthesis of benzylidenemalononitrile compounds under microwave irradiation. Current Organic Chemistry, v. 26, n. 16, p. 1552-1564 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.2174/1385272827666221125091631. Acesso em: 10 nov. 2024.
APA
Jimenez, D. E. Q., Zanin, L. L., Ferreira, I. M., Deflon, V. M., Diniz, L. F., Ellena, J., et al. (2022). Sustainable synthesis of benzylidenemalononitrile compounds under microwave irradiation. Current Organic Chemistry, 26( 16), 1552-1564 + supplementary material. doi:10.2174/1385272827666221125091631
NLM
Jimenez DEQ, Zanin LL, Ferreira IM, Deflon VM, Diniz LF, Ellena J, Haiduke RLA, Porto ALM. Sustainable synthesis of benzylidenemalononitrile compounds under microwave irradiation [Internet]. Current Organic Chemistry. 2022 ; 26( 16): 1552-1564 + supplementary material.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272827666221125091631
Vancouver
Jimenez DEQ, Zanin LL, Ferreira IM, Deflon VM, Diniz LF, Ellena J, Haiduke RLA, Porto ALM. Sustainable synthesis of benzylidenemalononitrile compounds under microwave irradiation [Internet]. Current Organic Chemistry. 2022 ; 26( 16): 1552-1564 + supplementary material.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1385272827666221125091631
Artigo de periodico
6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility (2022)
Britto Júnior, José ; Silva Filho, Walter Pinto da; Amorim, Amanda Consulin; Campos, Rafael ; Moraes, Manoel Odorico ; Moraes, Maria Elisabete A. ; Fregonesi, Adriano ; Monica, Fabiola Zakia ; Antunes, Edson ; De Nucci, Gilberto
Source: Andrology. Unidade: ICB
Subjects: FARMACOLOGIA, RECEPTORES DE DOPAMINA, ÓXIDO NÍTRICO, ANTIDEPRESSIVOS, CATECOLAMINAS, ADRENÉRGICOS, ADRENORECEPTORES, RATOS, RECEPTORES ADRENÉRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITTO JÚNIOR, José et al. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology, 2022Tradução . . Disponível em: https://doi.org/10.1111/andr.13263. Acesso em: 10 nov. 2024.
APA
Britto Júnior, J., Silva Filho, W. P. da, Amorim, A. C., Campos, R., Moraes, M. O., Moraes, M. E. A., et al. (2022). 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology. doi:10.1111/andr.13263
NLM
Britto Júnior J, Silva Filho WP da, Amorim AC, Campos R, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility [Internet]. Andrology. 2022 ;[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/andr.13263
Vancouver
Britto Júnior J, Silva Filho WP da, Amorim AC, Campos R, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility [Internet]. Andrology. 2022 ;[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/andr.13263
Artigo de periodico
Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides (2022)
Silva, João Vitor da ; Savino, Débora Feliciano; Hirata, Mario Hiroyuki ; Ferreira, Glaucio Monteiro ; Giarolla, Jeanine
Source: Protein and Peptide Letters. Unidade: FCF
Subjects: ZIKA VÍRUS, PEPTÍDEOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Vitor da et al. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, v. 29, p. 901-910, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220919143316. Acesso em: 10 nov. 2024.
APA
Silva, J. V. da, Savino, D. F., Hirata, M. H., Ferreira, G. M., & Giarolla, J. (2022). Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, 29, 901-910. doi:10.2174/0929866529666220919143316
NLM
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Vancouver
Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929866529666220919143316
Artigo de periodico
Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition (2021)
Ribeiro, Rayssa; Eloy, Mariana A; Francisco, Carla S; Javarini, Clara l; Ayusso, Gabriela M; Fonseca, Victor da Rocha; Romão, Wanderson; Regasini, Luis Octávio; Araujo, Sheila C; Almeida, Michell Oliveira ; Honório, Káthia Maria ; Paula, Heberth De; Lacerda Júnior, Valdemar ; Morais, Pedro Alves Bezerra
Source: Current Topics in Medicinal Chemistry. Unidades: EACH, IQSC
Subjects: LEUCEMIA, ENZIMAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Rayssa et al. Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition. Current Topics in Medicinal Chemistry, v. 21, p. 1999-2017, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210705170047. Acesso em: 10 nov. 2024.
APA
Ribeiro, R., Eloy, M. A., Francisco, C. S., Javarini, C. l, Ayusso, G. M., Fonseca, V. da R., et al. (2021). Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition. Current Topics in Medicinal Chemistry, 21, 1999-2017. doi:10.2174/1568026621666210705170047
NLM
Ribeiro R, Eloy MA, Francisco CS, Javarini C l, Ayusso GM, Fonseca V da R, Romão W, Regasini LO, Araujo SC, Almeida MO, Honório KM, Paula HD, Lacerda Júnior V, Morais PAB. Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1999-2017.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1568026621666210705170047
Vancouver
Ribeiro R, Eloy MA, Francisco CS, Javarini C l, Ayusso GM, Fonseca V da R, Romão W, Regasini LO, Araujo SC, Almeida MO, Honório KM, Paula HD, Lacerda Júnior V, Morais PAB. Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1999-2017.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1568026621666210705170047
Artigo de periodico
Proteomic analysis of intra- and extracellular proteins of aspergillus niveus during submerged bioprocess culturing under different pH conditions (2021)
Leite, Juliana Abigail; Rosa-Garzon, Nathália Gonsales da ; Laure, Hélen Julie; Rosa, José César ; Franco, Octavio Luiz; Motta, Cristina Maria de Souza; Cabral, Hamilton
Source: Current Proteomics. Unidades: FCFRP, FMRP
Subjects: ASPERGILLUS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Juliana Abigail et al. Proteomic analysis of intra- and extracellular proteins of aspergillus niveus during submerged bioprocess culturing under different pH conditions. Current Proteomics, v. 18, n. 4, p. 563-674, 2021Tradução . . Disponível em: https://doi.org/10.2174/1570164617999201202120657. Acesso em: 10 nov. 2024.
APA
Leite, J. A., Rosa-Garzon, N. G. da, Laure, H. J., Rosa, J. C., Franco, O. L., Motta, C. M. de S., & Cabral, H. (2021). Proteomic analysis of intra- and extracellular proteins of aspergillus niveus during submerged bioprocess culturing under different pH conditions. Current Proteomics, 18( 4), 563-674. doi:10.2174/1570164617999201202120657
NLM
Leite JA, Rosa-Garzon NG da, Laure HJ, Rosa JC, Franco OL, Motta CM de S, Cabral H. Proteomic analysis of intra- and extracellular proteins of aspergillus niveus during submerged bioprocess culturing under different pH conditions [Internet]. Current Proteomics. 2021 ; 18( 4): 563-674.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1570164617999201202120657
Vancouver
Leite JA, Rosa-Garzon NG da, Laure HJ, Rosa JC, Franco OL, Motta CM de S, Cabral H. Proteomic analysis of intra- and extracellular proteins of aspergillus niveus during submerged bioprocess culturing under different pH conditions [Internet]. Current Proteomics. 2021 ; 18( 4): 563-674.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1570164617999201202120657
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 10 nov. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Artigo de periodico
Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells (2021)
Pepino, Rebeka de Oliveira ; Coelho, Fernanda; Janku, Tatiane Aparecida Buzanello ; Alencar, Diandra Pinheiro ; Azevedo Jr, Walter Figueira de ; Canduri, Fernanda
Source: Current Medicinal Chemistry. Unidade: IQSC
Subjects: BIOQUÍMICA, BIOLOGIA MOLECULAR, NEOPLASIAS, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEPINO, Rebeka de Oliveira et al. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells. Current Medicinal Chemistry, v. 28, p. 6846-6865, 2021Tradução . . Disponível em: https://doi.org/10.2174/092986732866621032912214. Acesso em: 10 nov. 2024.
APA
Pepino, R. de O., Coelho, F., Janku, T. A. B., Alencar, D. P., Azevedo Jr, W. F. de, & Canduri, F. (2021). Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells. Current Medicinal Chemistry, 28, 6846-6865. doi:10.2174/092986732866621032912214
NLM
Pepino R de O, Coelho F, Janku TAB, Alencar DP, Azevedo Jr WF de, Canduri F. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells [Internet]. Current Medicinal Chemistry. 2021 ; 28 6846-6865.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/092986732866621032912214
Vancouver
Pepino R de O, Coelho F, Janku TAB, Alencar DP, Azevedo Jr WF de, Canduri F. Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells [Internet]. Current Medicinal Chemistry. 2021 ; 28 6846-6865.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/092986732866621032912214
Artigo de periodico
Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents (2021)
Gaspari, Ana Paula Segantin ; Silva, Roberto Santana da; Carneiro, Zumira Aparecida; Carvalho, Marcelo Rodrigues de; Carvalho, Ivone ; Pernomian, Laena ; Ferreira, Lucimara P.; Ramos, Loyanne Carla Barbosa; Souza, Gabriel Aguiar de; Formiga, André Luiz Barboza
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidades: FCFRP, FMRP
Subjects: AMINOÁCIDOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPARI, Ana Paula Segantin et al. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, v. 21, n. 12, p. 1602-1611, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666201020155105. Acesso em: 10 nov. 2024.
APA
Gaspari, A. P. S., Silva, R. S. da, Carneiro, Z. A., Carvalho, M. R. de, Carvalho, I., Pernomian, L., et al. (2021). Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, 21( 12), 1602-1611. doi:10.2174/0929867327666201020155105
NLM
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929867327666201020155105
Vancouver
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2174/0929867327666201020155105

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration